Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Macrophages are more involved in Lichen planopilaris than in Frontal fibrosing alopecia.

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

Mycophenolic acid may help hair growth, a combination treatment improves hair thickness in male hair loss, and early treatment of frontal fibrosing alopecia is important.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

Frontal fibrosing alopecia can be misdiagnosed as androgenetic alopecia in African American women.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

FFA's causes may include environmental triggers and genetic factors.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.